Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
In this study, we aim to describe the circulation patterns of the influenza B/Victoria and B/Yamagata lineages in South Africa
and to determine the factors associated with hospitalization for SARI following infection with influenza B/Victoria or B/
Yamagata lineages. Data for influenza B in South Africa are limited and the molecular epidemiology was previously described
for the period of 1998-2001. The study enrolled patients from three influenza surveillance programs (Viral Watch, SARI and
ILI) running in South Africa between year 2005 and 2014. Initially, starting from 2005 to 2008, influenza was diagnosed
through virus isolation and antigenic characterization. From 2009, the technology of use was changed to real-time PCR assays.
Influenza B vaccine strains recommended for the Southern Hemisphere were mismatched to the dominant circulating lineage
in 2005, 2008, 2009 and 2011. Factors associated with infection with a specific influenza B lineage were assessed using the
Fisher�s exact test. P-values <0.05 were considered to be statistically significant. Analysis was performed using STATA 13.
In SARI cases, the overall frenquency of B/Victoria lineage (181/286 [63.3%]) was higher than that of B/Yamagata lineage
(105/286 [36.7%]) from the year 2005 to 2014. The highest incidence of influenza B associated with severe lower respiratory
tract infections was seen in the age group 0 to 4 (199/482 [41%]), followed by the age group 25 to 44 (146/482 [40%]), and the
age group +65 has the lowest incidence (22/482 [5%]). The overall HIV incidene in the SARI case with influenza B is 99/235
(42%).